Ethanol increases osteoclastogenesis associated with the increased expression of RANK, PU.1 and MITF in vitro and in vivo

International Journal of Molecular Medicine

Volumn 30, Issue 1, 2012, Pages 165-172

  Iitsuka, Natsumi ^a   Hie, Mamiko ^a   Nakanishi, Atsuko ^a   Tsukamoto, Ikuyo ^a  

^a NARA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Ethanol; Microphthalmia associated trascription factor; Osteoclastogenesis; PU.1; Receptor for activation of nf b

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALCOHOL; ALKALINE PHOSPHATASE; CATHEPSIN K; COLONY STIMULATING FACTOR 1; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPID PEROXIDE; MESSENGER RNA; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCALCIN; PROTEIN C FOS; PROTEIN C JUN; REACTIVE OXYGEN METABOLITE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TRANSCRIPTION FACTOR PU 1;

ANIMAL EXPERIMENT; ARTICLE; BONE METABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MONOCYTE MACROPHAGE PRECURSOR CELL; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT;

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; ANIMALS; BONE RESORPTION; CATHEPSIN K; CELL DIFFERENTIATION; ETHANOL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLUTATHIONE; ISOENZYMES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPID PEROXIDES; MACROPHAGES; MALE; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; NF-KAPPA B; OSTEOCALCIN; OSTEOCLASTS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RNA, MESSENGER; TRANS-ACTIVATORS;

EID: 84861472343     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.974     Document Type: Article

References (31)

1. Turner RT: Skeletal response to alcohol. Alcohol Clin Exp Res 24: 1693-1701, 2000.
2. Manolagas SC: Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21: 115-137, 2000.
3. Rodan GA and Martin TJ: Therapeutic approaches to bone diseases. Science 289: 1508-1514, 2000.
4. Chakkalakal DA: Alcohol-induced bone loss and deficient bone repair. Alcohol Clin Exp Res 29: 2077-2090, 2005.
5. Callaci JJ, Himes R, Lauing K, Wezeman FH and Brownson K: Binge alcohol-induced bone damage is accompanied by differential expression of bone remodeling-related genes in rat vertebral bone. Calcif Tissue Int 84: 474-484, 2009.
6. Dai J, Lin D, Zhang J, et al: Chronic alcohol ingestion induces osteoclastogenesis and bone loss through IL-6 in mice. J Clin Invest 106: 887-895, 2000.
7. Udagawa N, Takahashi N, Akatsu T, et al: Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci USA 87: 7260-7264, 1990.
8. Harada S and Rodan GA: Control of osteoblast function and regulation of bone mass. Nature 423: 349-355, 2003. (Pubitemid 40852710)
9. Asagiri M and Takayanagi H: The molecular understanding of osteoclast differentiation. Bone 40: 251-264, 2007. (Pubitemid 46054562)
10. Hie M and Tsukamoto I: Vitamin C-deficiency stimulates osteoclastogenesis with an increase in RANK expression. J Nutr Biochem 22: 164-171, 2011.
11. Hie M and Tsukamoto I: Administration of zinc inhibits osteoclastogenesis through the suppression of RANK expression in bone. Eur J Pharmacol 668: 140-146, 2011.
12. Novitskiy G, Traore K, Wang L, Trush MA and Mezey E: Effects of ethanol and acetaldehyde on reactive oxygen species production in rat hepatic stellate cells. Alcohol Clin Exp Res 30: 1429-1435, 2006. (Pubitemid 44114695)
13. Polikandriotis JA, Rupnow HL, Elms SC, et al: Chronic ethanol ingestion increases superoxide production and NADPH oxidase expression in the lung. Am J Respir Cell Mol Biol 34: 314-319, 2006. (Pubitemid 43320712)
14. Chen JR, Shankar K, Nagarajan S, Badger TM and Ronis MJ: Protective effects of estradiol on ethanol-induced bone loss involve inhibition of reactive oxygen species generation in osteoblasts and downstream activation of the extracellular signal-regulated kinase/signal transducer and activator of transcription 3/receptor activator of nuclear factor-kappaB ligand signaling cascade. J Pharmacol Exp Ther 324: 50-59, 2008. (Pubitemid 350294156)
15. Ohkawa H, Ohishi N and Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358, 1979. (Pubitemid 9194347)
16. Ellman GL: Tissue sulfhydryl groups. Arch Biochem Biophys 82: 70-77, 1959.
17. Goto A and Tsukamoto I: Increase in tartrate-resistant acid phosphatase of bone at the early stage of ascorbic acid deficiency in the ascorbate-requiring Osteogenic Disorder Shionogi (ODS) rat. Calcif Tissue Int 73: 180-185, 2003. (Pubitemid 37082365)
18. Hie M, Shimono M, Fujii K and Tsukamoto I: Increased cathepsin K and tartrate-resistant acid phosphatase expression in bone of streptozotocin-induced diabetic rats. Bone 41: 1045-1050, 2007. (Pubitemid 350116747)
19. Parfitt AM, Drezner MK, Glorieux FH, et al: Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2: 595-610, 1987.
20. Sato T, Shibata T, Ikeda K and Watanabe K: Generation of bone-resorbing osteoclasts from B220+ cells: its role in accelerated osteoclastogenesis due to estrogen deficiency. J Bone Miner Res 16: 2215-2221, 2001. (Pubitemid 33104711)
21. Hie M, Yamazaki M and Tsukamoto I: Curcumin suppresses increased bone resorption by inhibiting osteoclastogenesis in rats with streptozotocin-induced diabetes. Eur J Pharmacol 621: 1-9, 2009.
22. Sampson HW, Chaffin C, Lange J and DeFee B II: Alcohol consumption by young actively growing rats: a histomorphometric study of cancellous bone. Alcohol Clin Exp Res 21: 352-359, 1997. (Pubitemid 27176289)
23. Sudo T, Nishikawa S, Ogawa M, et al: Functional hierarchy of c-kit and c-fms in intramarrow production of CFU-M. Oncogene 11: 2469-2476, 1995. (Pubitemid 26023814)
24. Hayashi S, Miyamoto A, Yamane T, et al: Osteoclast precursors in bone marrow and peritoneal cavity. J Cell Physiol 170: 241-247, 1997. (Pubitemid 27117907)
25. Arai F, Miyamoto T, Ohneda O, et al: Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J Exp Med 190: 1741-1754, 1999. (Pubitemid 30013841)
26. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT and Martin TJ: Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20: 345-357, 1999. (Pubitemid 30649812)
27. Riggs BL: The mechanisms of estrogen regulation of bone resorption. J Clin Invest 106: 1203-1204, 2000.
28. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ and Riggs BL: The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15: 2-12, 2000. (Pubitemid 30026926)
29. Ishii J, Kitazawa R, Mori K, et al: Lipopolysaccharide suppresses RANK gene expression in macrophages by down-regulating PU.1 and MITF. J Cell Biochem 105: 896-904, 2008.
30. Bai XC, Lu D, Liu AL, et al: Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast. J Biol Chem 280: 17497-17506, 2005. (Pubitemid 41389222)
31. Jackson SH, Devadas S, Kwon J, Pinto LA and Williams MS: T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol 5: 818-827, 2004. (Pubitemid 39172975)